SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-005496
Filing Date
2024-08-12
Accepted
2024-08-12 16:05:09
Documents
15
Period of Report
2024-08-07
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sunshine_8k.htm   iXBRL 8-K 28070
2 CERTIFICATE OF AMENDMENT sunshine_ex0301.htm EX-3.1 9209
  Complete submission text file 0001683168-24-005496.txt   258470

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE sbfm-20240807.xsd EX-101.SCH 3553
4 XBRL DEFINITION FILE sbfm-20240807_def.xml EX-101.DEF 26585
5 XBRL LABEL FILE sbfm-20240807_lab.xml EX-101.LAB 36550
6 XBRL PRESENTATION FILE sbfm-20240807_pre.xml EX-101.PRE 25209
17 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_8k_htm.xml XML 5640
Mailing Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301
Business Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 954-515-0810
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41282 | Film No.: 241196715
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)